| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Rothbaum Wayne P. serves as a Director at IOVA. Across recent SEC filings that breaks down to 7 buys and 0 sells. Those positions are worth an estimated $172.5M at current prices.
Historically, Rothbaum Wayne P.'s trades have earned a middling insider score of 60/100 across 5 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +20.2%.
The biggest single holding is IOVA (~$172.5M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 22,221,053 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 5,000,000 | $9.15 | $45,750,000.00 | +21.7% | -14.0% | -53.0% | |
| Sep 15, 2023 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 5,000,000 | $5.30 | $26,500,000.00 | +27.7% | +46.3% | +96.2% | |
| Dec 2, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 10,000,000 | $6.50 | $65,000,000.00 | +124.0% | +4.1% | -8.5% | |
| Jun 1, 2022 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 1,000,000 | $6.60 | $6,600,050.00 | +6.8% | +63.8% | +36.8% | |
| Dec 6, 2018 | IOVA Iovance Biotherapeutics, Inc. | Director | Buy | 1,221,053 | $10.20 | $12,454,056.43 | +9.7% | - | - |